Skyward Specialty Insurance Group, Inc. (SKWD)

NASDAQFinancialsInsurance - Property & CasualtySnapshot 2026-10-23

$60.39-2.85%

Close 2026-10-23 · 1-day change

Investment OutlookAs of Oct 24, 2026

What could strengthen or challenge Skyward Specialty Insurance Group, Inc.’s outlook?

The long-term thesis, the evidence coming in, and the environment around it. Thesis dated Jul 8, 2026.

Higher potential upsideImproving expectations

Next-FY EPS estimate change · 30 days

-0.1%

+10% or more+5%0%−5%−10% or less

5.53 → 5.52 EPS · FY ending Dec 31, 2027 · 7 analysts

Higher risk of downsideWeakening expectations

One observable signal. This measures changing earnings expectations, not the probability of a gain or loss.

How this is measured

Change in the same fiscal period’s mean EPS estimate from Sep 24, 2026 to Oct 24, 2026: (new ÷ prior − 1). Contributor count changed from 7 to 7; this is not the number of analysts revising. Source: FMP consensus snapshots. The ±10% axis is a display range.

Measure / period	Management expectations	Analyst expectations
Quarter ending 2026-12-30
Revenue	—	566.94M
EPS	—	1.259
Annual ending 2026-12-31
Revenue	—	2.73B
EPS	—	5.025
Annual ending 2027-12-31
Revenue	—	2.98B
EPS	—	5.524

Management figures unavailable.

What the Thesis Depends On

4 published thesis conditions, with dated milestones shown separately.

Key Factor	Why It Matters	Current Status	Break Condition	Latest Evidence
Successful integration of Apollo acquisition	A supporting condition in Skyward Specialty Insurance Group, Inc.'s published investment case. The stated target is Complete integration and realize synergies.	Intact	Acquisition fails to complete or integration falters	Qualitative condition This condition has no defined numerical measure. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Prudent use of capital including buybacks and debt	A supporting condition in Skyward Specialty Insurance Group, Inc.'s published investment case. The stated target is Maintain manageable debt and continue buybacks.	Intact	Debt or buybacks materially harm financial stability	Buyback authorization $100M vs qualitative target Board approved expansion of share repurchase program from $50M to $100M on July 15, 2026. Context reviewed through Oct 23, 2026Last status assessment Oct 24, 2026Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
EPS of at least $1.25 next year	Profit per share is expected to rise to $1.25 next year.	Intact	EPS falls below $1.25 in FY26	Diluted EPS: $1.07 per share FY2026-Q2; GAAP. Published target: >=1.25 USD per share. Target period is not explicitly aligned with this observation. Source published Aug 7, 20261.07 USD/share · source valueSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: d6692ff4-9289-479d-bdc3-426477c81bd0. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.
Annual revenue growth of about 22%	A primary condition in Skyward Specialty Insurance Group, Inc.'s published investment case. The stated target is >=21.6% YoY.	Intact	YoY revenue growth falls below 21.6% in FY26	Revenue growth: 53.03% FY2026-Q2; GAAP. Published target: >=21.6% YoY. Target period is not explicitly aligned with this observation. Source published Aug 7, 202653.025448 percent · calculatedSource reportLast status assessment Oct 24, 2026 Measurement source consolidated · GAAP FY2026-Q2 · Period ending Jun 30, 2026 Source: company_financial_results. Reference: d6692ff4-9289-479d-bdc3-426477c81bd0. Source status: eligible. Compare required operating outcomes Compare scope, accounting basis and period before treating this evidence as progress against an annual requirement.

Stored thesis · Jul 8, 2026. Latest Evidence uses source-matched measurements where available, alongside the last thesis-monitor assessment. Source periods and assessment dates are shown separately. A new measurement does not automatically change the published status or verify an older target.

Incoming Evidence

Compare these dated observations with the operating requirements above

Expectations trend

Same fiscal period

FY2027 · fiscal year ending 2027-12-31 · fmp

FY2027 EPS$5.52

$5.48 → $5.52 · observed estimates

FY2027 revenue$2.98B

Unavailable → $2.98B · observed estimates

Exact estimates & source dates

One fiscal period and provider throughout. At least five contributors are required for each plotted metric; missing coverage stays a gap. Axes show the observed range. Counts measure coverage, not revisions.

FY2027 estimate observations · fmp
Snapshot	EPS	Revenue	EPS / revenue analysts
2026-07-24	$5.48	Unavailable	7 / 4
2026-07-25	$5.48	$2,097,686,200	12 / 5
2026-07-26	$5.48	$2,097,686,200	12 / 5
2026-07-27	$5.48	$2,097,686,200	12 / 5
2026-07-28	$5.48	$2,097,686,200	12 / 5
2026-07-29	$5.48	$2,097,686,200	12 / 5
2026-07-30	$5.48	Unavailable	7 / 4
2026-07-31	$5.48	Unavailable	7 / 4
2026-08-01	$5.48	Unavailable	7 / 4
2026-08-02	$5.48	$2,097,686,200	12 / 5
2026-08-03	$5.48	Unavailable	7 / 4
2026-08-04	$5.48	$2,097,686,200	12 / 5
2026-08-05	$5.48	Unavailable	7 / 4
2026-08-06	$5.48	Unavailable	7 / 4
2026-08-08	$5.52	$2,092,477,200	12 / 5
2026-08-09	$5.52	$2,092,477,200	12 / 5
2026-08-10	$5.52	$2,092,477,200	12 / 5
2026-08-12	$5.52	Unavailable	7 / 4
2026-08-13	$5.53	$2,101,025,290	12 / 7
2026-08-14	$5.52	Unavailable	7 / 4
2026-08-15	$5.52	$2,896,726,494	7 / 5
2026-08-16	$5.52	$2,896,726,494	7 / 5
2026-08-17	$5.52	$2,896,726,494	7 / 5
2026-08-18	$5.52	$2,896,726,494	7 / 5
2026-08-19	$5.52	$2,896,726,494	7 / 5
2026-08-20	$5.53	$2,983,535,357	7 / 5
2026-08-21	$5.53	$2,983,535,357	7 / 5
2026-08-22	$5.53	$2,983,535,357	7 / 5
2026-08-23	$5.53	$2,983,535,357	7 / 5
2026-08-24	$5.53	$2,983,535,357	7 / 5
2026-08-25	$5.53	$2,983,535,357	7 / 5
2026-08-26	$5.53	$2,983,535,357	7 / 5
2026-08-27	$5.53	$2,983,535,357	7 / 5
2026-08-28	$5.53	$2,983,535,357	7 / 5
2026-08-29	$5.53	$2,983,535,357	7 / 5
2026-08-30	$5.53	$2,983,535,357	7 / 5
2026-08-31	$5.53	$2,983,535,357	7 / 5
2026-09-01	$5.53	$2,983,535,357	7 / 5
2026-09-02	$5.53	$2,983,535,357	7 / 5
2026-09-03	$5.53	$2,983,535,357	7 / 5
2026-09-04	$5.53	$2,983,535,357	7 / 5
2026-09-05	$5.53	$2,983,535,357	7 / 5
2026-09-06	$5.53	$2,983,535,357	7 / 5
2026-09-07	$5.53	$2,983,535,357	7 / 5
2026-09-08	$5.53	$2,983,535,357	7 / 5
2026-09-09	$5.53	$2,983,535,357	7 / 5
2026-09-10	$5.53	$2,983,535,357	7 / 5
2026-09-11	$5.53	$2,983,535,357	7 / 5
2026-09-12	$5.53	$2,983,535,357	7 / 5
2026-09-13	$5.53	$2,983,535,357	7 / 5
2026-09-14	$5.53	$2,983,535,357	7 / 5
2026-09-15	$5.53	$2,983,535,357	7 / 5
2026-09-16	$5.53	$2,983,535,357	7 / 5
2026-09-17	$5.53	$2,983,535,357	7 / 5
2026-09-18	$5.53	$2,983,535,357	7 / 5
2026-09-19	$5.53	$2,983,535,357	7 / 5
2026-09-20	$5.53	$2,983,535,357	7 / 5
2026-09-21	$5.53	$2,983,535,357	7 / 5
2026-09-22	$5.53	$2,983,535,357	7 / 5
2026-09-23	$5.53	$2,983,535,357	7 / 5
2026-09-24	$5.53	$2,983,535,357	7 / 5
2026-09-25	$5.53	$2,983,535,357	7 / 5
2026-09-26	$5.53	$2,983,535,357	7 / 5
2026-09-27	$5.53	$2,983,535,357	7 / 5
2026-09-28	$5.53	$2,983,535,357	7 / 5
2026-09-29	$5.53	$2,983,535,357	7 / 5
2026-09-30	$5.53	$2,983,535,357	7 / 5
2026-10-01	$5.53	$2,983,535,357	7 / 5
2026-10-02	$5.53	$2,983,535,357	7 / 5
2026-10-03	$5.53	$2,983,535,357	7 / 5
2026-10-04	$5.53	$2,983,535,357	7 / 5
2026-10-05	$5.53	$2,983,535,357	7 / 5
2026-10-06	$5.53	$2,983,535,357	7 / 5
2026-10-07	$5.52	$2,983,535,357	7 / 5
2026-10-08	$5.52	$2,983,535,357	7 / 5
2026-10-09	$5.52	$2,983,535,357	7 / 5
2026-10-10	$5.52	$2,983,535,357	7 / 5
2026-10-11	$5.52	$2,983,535,357	7 / 5
2026-10-12	$5.52	$2,983,535,357	7 / 5
2026-10-13	$5.52	$2,983,535,357	7 / 5
2026-10-14	$5.52	$2,983,535,357	7 / 5
2026-10-15	$5.52	$2,983,535,357	7 / 5
2026-10-16	$5.52	$2,983,535,357	7 / 5
2026-10-17	$5.52	$2,983,535,357	7 / 5
2026-10-18	$5.52	$2,983,535,357	7 / 5
2026-10-19	$5.52	$2,983,535,357	7 / 5
2026-10-20	$5.52	$2,983,535,357	7 / 5
2026-10-21	$5.52	$2,983,535,357	7 / 5
2026-10-22	$5.52	$2,983,535,357	7 / 5
2026-10-23	$5.52	$2,983,535,357	7 / 5
2026-10-24	$5.52	$2,983,535,357	7 / 5

Revenue and EPS estimates track expectations. They are not delivered results or like-for-like proof of a required annual path.

Compare required revenue and earnings

Analyst view

Monthly observations

Buy / Strong BuyHoldSell / Strong Sell

Exact monthly counts

Monthly rating snapshots · fmp. Missing snapshots are not zero.
Date	Buy*	Hold
2026-05-01	9	4
2026-06-01	9	4
2026-07-01	9	4
2026-08-01	9	4
2026-09-01	9	4
2026-10-01	9	4

*Buy includes Strong Buy; Sell includes Strong Sell. Monthly counts describe the analyst mix, not the firms behind each recent action.

Latest: 9 Buy / Strong Buy · 4 Hold · 0 Sell / Strong Sell

0 upgrades0 downgrades0 maintains

Recent actions · Sep 25–Oct 24 · 0 recorded

Price-target changes

30 days

Individual price-target observations are unavailable.

0 raises · 0 cuts · 0 unchanged · 0 without a comparable prior

How this is measured

Sep 25, 2026–Oct 24, 2026. Each firm's latest positive target is paired only with its immediately prior positive target from the same provider, at most 180 days earlier. Unmatched observations have one dot; conflicting observations are not compared.

Outlook in Brief

The evidence, the remaining questions, and what comes next

What's improving

No recovery evidence is reported in the available driver assessments.

Still unresolved / key risks

Successful integration of Apollo acquisitionQualitative condition
EPS of at least $1.25 next yearDiluted EPS: $1.07 per share
Annual revenue growth of about 22%Revenue growth: 53.03%

Next proof point

Nov 5, 2026

Look for updated results and guidance against the published targets, plus direct evidence for unresolved drivers.

Review earnings

Bottom line

3 of 4 published conditions remain under pressure or need verification. The next results need to address those conditions.

The dated weekly assessment and its assumptions are available in Read detailed Outlook.

Historical risk context

Observed price history; separate from operating scenarios

Price sensitivity

1.5%Typical daily move · historical

Downside history

-20.8%Maximum drawdown · trailing year

Read detailed Outlook Company context, assumptions & risks

Skyward Specialty Insurance Group, Inc. outlook in detail

The weekly editorial context below is a separate assessment from the dated monitor evidence above. Recovery observations do not automatically change the published thesis. Unverified outside influences are hypotheses, not measured driver evidence.

Updated Oct 24, 2026

What kind of bet this is

This is a growth-oriented insurer whose multi-year view depends on expanding premiums while keeping underwriting disciplined. The thesis is intact, but confidence has eased from high to medium.

What's priced into Skyward Specialty Insurance Group, Inc.

Valuation is 1.17 times the peer level, so SKWD carries a premium. The expectations gap is negative, which points to expectations sitting above the model’s view, though model confidence is low; overall, the snapshot labels what is priced in as justified.

What the fundamentals likely do

Recent results are strong: gross written premiums rose 13.3% and managed premiums rose 17.5% year over year, while the combined ratio, a measure of claims and expenses relative to premiums, stayed at 89.5% in the first two quarters of 2026. Near term, a guidance cut is a key risk; miss risk is described as low, but past deep misses and a downward trend in earnings surprises warrant attention.

What Skyward Specialty Insurance Group, Inc. hinges on

The multi-year view hinges on continued premium growth without weakening underwriting discipline. Near term, a guidance cut or lower interest rates would weigh on the setup, while continued strong earnings and higher guidance from sector peers could support sector momentum.